Tumor neuroendokrin pankreas Dokter Terbaik di Israel - TOP-18 dokter

Prof. Merimsky memimpin Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center – program sarkoma terbesar di Israel.

• Spesialisasi lebih dari 25 tahun dalam tumor neuroendokrin
• Anggota fakultas ESMO untuk pengobatan sarkoma
• Menyelesaikan fellowship di Institut Gustave Roussy di Paris
• Banyak memublikasikan karya ilmiah tentang pengobatan tumor langka

Dr. Pelles Sharon berspesialisasi dalam tumor neuroendokrin pankreas, menawarkan perawatan mutakhir seperti bedah Whipple dan HIPEC di Sourasky Medical Center.

• Berpengalaman dalam berbagai operasi dan terapi kanker
• Melakukan penelitian klinis untuk meningkatkan pemahaman pasien tentang uji klinis
• Memberikan rencana perawatan pribadi termasuk imunoterapi dan terapi target

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Mengepalai Divisi Onkologi Medis di Pusat Medis Sourasky Israel – salah satu rumah sakit universitas utama di negara tersebut.

• Mengambil spesialisasi dalam penyakit dalam dan onkologi medis di Pusat Medis Sheba
• Memiliki gelar dari Universitas Ben Gurion di Negev
• Berbicara bahasa Inggris dengan lancar, membuat konsultasi internasional menjadi lancar

Pemimpin Inisiatif Kedokteran Genomik Nasional Israel – Dr. Raphael spesialisasi dalam pemprofilan genomik tingkat lanjut untuk tumor neuroendokrin pankreas di Sourasky Medical Center.

• Dosen senior di Fakultas Kedokteran Tel Aviv University
• Penyelidik utama untuk berbagai uji klinis di bidang onkologi
• Ahli dalam biopsi cair dan pemprofilan genomik tumor yang komprehensif
• Anggota European Society of Medical Oncology dan IASLC

Irina Stepfansky adalah direktur rawat inap onkologi di Tel Aviv Medical Center (Ichilov) – rumah sakit terkemuka terakreditasi JCI di Israel.

• Lebih dari 25 tahun pengalaman medis sejak memulai praktik
• Pelatihan khusus dalam onkologi di departemen terkemuka Ichilov
• Bekerja sebagai peneliti utama dalam uji klinis fase I-III untuk obat kanker baru
• Sertifikasi dewan dalam kedokteran internal dan onkologi klinis

Kepala Departemen Bedah Kolorektal di Sourasky Medical Center – spesialis terkemuka dalam operasi Whipple untuk tumor neuroendokrin pankreas.

• Pengalaman lebih dari 20 tahun sebagai ahli bedah abdomen
• Melakukan prosedur bedah terbuka maupun invasif minimal
• Ahli dalam teknik Whipple (pankreatoduodenektomi) yang kompleks

Salah satu ahli bedah Whipple terbaik di Israel, Dr. Klauzner mengepalai Departemen Bedah di Sourasky Medical Center.

• Lebih dari 45 tahun pengalaman bedah
• Spesialisasi dalam prosedur kolorektal dan pankreas yang kompleks
• Keahlian luas dalam bedah kanker gastrointestinal
• Memimpin tim bedah papan atas di rumah sakit besar di Tel Aviv

Dr. Inna Ospovat adalah spesialis terkemuka dalam PRRT Lutetium-177, merintis terapi terobosan ini secara global.

• Memimpin departemen terapi nuklir di Ichilov – salah satu dari sedikit pusat yang menawarkan pengobatan ini
• Spesialisasi dalam onkologi dan terapi radiasi di Rumah Sakit Universitas Hadassah
• Anggota ASTRO dan Perhimpunan Onkologi Klinis Israel
• Ahli dalam perawatan radiobiologis untuk tumor gastrointestinal

Dr. Ayala Hubert adalah Kepala Pusat Kanker Gastrointestinal di Hadassah Medical Center – spesialis dalam kanker sistem pencernaan.

• 33 tahun pengalaman sebagai ahli onkologi medis dan radioterapis
• Terlatih dalam psikologi di Hebrew University – memberikan pendekatan manusiawi pada perawatan kanker
• Memiliki sertifikasi dewan baik dalam Onkologi maupun Radioterapi
• Anggota aktif Komite Israel untuk Kanker Gastrointestinal

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.